Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 13 citing articles:

Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma
Sami Fares, Chase J. Wehrle, Hanna Hong, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1453-1453
Open Access | Times Cited: 14
Tumor Mutational Burden from Circulating Tumor DNA Predicts Recurrence of Hepatocellular Carcinoma After Resection: An Emerging Biomarker for Surveillance
Chase J. Wehrle, Hanna Hong, Suneel D. Kamath, et al.
Annals of Surgery (2024)
Closed Access | Times Cited: 11
Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab
Ying‐Chun Shen, Tsung‐Hao Liu, Alan Nicholas, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 34, pp. 4060-4070
Closed Access | Times Cited: 6
PET-Assessed Metabolic Tumor Volume Across the Spectrum of Solid-Organ Malignancies: A Review of the Literature
Anusha Agarwal, Chase J. Wehrle, Sangeeta Satish, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 123-123
Open Access
Assessing the Causal Effect of Circulating Protein‐To‐Protein Ratio on the Risk of Morbidity of Hepatocellular Carcinoma
Qiuyuan Yue, Xiaoxia Li, Xiang Wan, et al.
Cancer Medicine (2025) Vol. 14, Iss. 1
Open Access
Expanding Indications in Transplant Oncology
Erlind Allkushi, Chase J. Wehrle, JaeKeun Kim, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 773-773
Open Access
Neoadjuvant therapy for hepatocellular carcinoma—priming precision innovations to transform HCC treatment
Kristin E. Goodsell, Alice Tao, James O. Park
Frontiers in Surgery (2025) Vol. 12
Open Access
Histotripsy of Liver Tumors: Patient Selection, Ethical Discussions, and How We Do It
Melis Uysal, Chase J. Wehrle, Sangeeta Satish, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1100-1100
Open Access
Systemic conversion therapies for initially unresectable hepatocellular carcinoma: a systematic review and meta-analysis
Hongwei Xu, Haili Zhang, Bo Li, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Circulating tumor DNA in management of primary liver malignancy: A review of the literature and future directions
Noah X. Tocci, Chase J. Wehrle, Keyue Sun, et al.
Journal of Surgical Oncology (2024)
Open Access
Locoregional Therapies and Interventional Radiology in Managing Hepatocellular Carcinoma: A Comprehensive Approach to Bridging, Downstaging, and Liver Transplantation
Juana V. Barrera, Leonard Dallag, Rubeel Akram, et al.
Digestive Disease Interventions (2024)
Closed Access
Abscopal Effect with Liver-Directed Therapy: A Review of the Current Literature and Future Directions
Jonah M. Levine, Alyssar Habib, Mikhail Silk, et al.
Livers (2024) Vol. 4, Iss. 4, pp. 601-614
Open Access
Advanced approaches to loco-regional and surgical management for hepatocellular carcinoma
Chase J. Wehrle, William H Archie, Dionisios Vrochides, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 6, pp. 2739-2742
Open Access
Page 1

Scroll to top